Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cara Therapeutics, Inc. (CARA)

« Back to company index

CARA Chatter Timeline

Stock Ticker for CARA

Most Active Tweeters for CARA

UserTweets
@OlympiaReport 6
@ConsumerFeed 4
@dispatchtribune 4
@whatsonthorold2 4
@WeekHerald 3

Recent Tweets for CARA

ConsumerFeed @ConsumerFeed
Cara Therapeutics $CARA Now Covered by Bank of America https://t.co/jcP3uRSMqK
January 18th 2019, 5:01pm
thefinreviewer @thefinreviewer
State Street Lifted Its Stake in Cara Therapeutics $CARA by $9.44 Million as Market Value Declined; Ubiquiti Networ… https://t.co/AY5R9jDjWQ
January 18th 2019, 1:01pm
LIGBeyond @LIGBeyond
$CARA watching lotta, bag-holders from $18+
January 17th 2019, 9:01am
newswithvalue @newswithvalue
$T $CARA: Jim Cramer Weighs In On Twitter, Deutsche Bank And More: https://t.co/UPHzERWEH2
January 17th 2019, 8:01am
OlympiaReport @OlympiaReport
Zacks Investment Research Lowers Cara Therapeutics $CARA to Sell https://t.co/SKvmgL0k5F
January 17th 2019, 1:01am
thefinreviewer @thefinreviewer
Blb&B Advisors Raised Its Boeing Co $BA Stake; Profile of 4 Analysts Covering Cara Therapeutics, Inc. $CARA https://t.co/q2EGZADChX
January 16th 2019, 11:01am
whatsonthorold2 @whatsonthorold2
Is there a Bearish outlook for Cara Therapeutics, Inc. $CARA this week? https://t.co/8aX8XoTioI
January 16th 2019, 9:01am
OlympiaReport @OlympiaReport
Cara Therapeutics $CARA Now Covered by Bank of America https://t.co/VtvujeFsHi
January 16th 2019, 9:01am
dispatchtribune @dispatchtribune
Cara Therapeutics $CARA Now Covered by Analysts at Bank of America https://t.co/LgxXtQYhHO
January 16th 2019, 9:01am
bbnsnews @bbnsnews
Cara Therapeutics $CARA Stock Rating Lowered by Zacks Investment Research https://t.co/SNYD6DtZBt
January 16th 2019, 2:01am
whatsonthorold2 @whatsonthorold2
Cara Therapeutics $CARA Is Now Covered By BofA Merrill. What can We Expect? https://t.co/EEDyRD3c9J https://t.co/rPNrHYoVvJ
January 15th 2019, 3:01pm
mmahotstuff1 @mmahotstuff1
Should Cara Therapeutics $CARA Shares Be Watched After Bank of America Initiates Coverage? https://t.co/SkoHgeUyJb https://t.co/1CZjLTk6hk
January 15th 2019, 2:01pm
davidmoadel @davidmoadel
$CARA Bank Of America Takes Neutral Stance On Cara Therapeutics Ahead Of Phase 3 Korsuva Results… https://t.co/XTKv7Lmgba
January 15th 2019, 1:01pm
newswithvalue @newswithvalue
$CARA: Bank Of America Takes Neutral Stance On Cara Therapeutics …: https://t.co/j1OKUx41JX
January 15th 2019, 11:01am
firsttomarkets @firsttomarkets
Cara Therapeutics Inc Initiated Coverage by Bank of America (Ranked 45th) to Neutral with $19PT $CARA #CARA https://t.co/TwWCsquQWC
January 15th 2019, 11:01am
AmericanBanking @AmericanBanking
Cara Therapeutics $CARA Receives New Coverage from Analysts at Bank of America https://t.co/E3tbwtM6zX #stocks
January 15th 2019, 8:01am
TheMarketsDaily @TheMarketsDaily
Bank of America Initiates Coverage on Cara Therapeutics $CARA https://t.co/bDg9k6DAIU
January 15th 2019, 8:01am
ThisLincolnian @ThisLincolnian
Zacks Investment Research Lowers Cara Therapeutics $CARA to Sell https://t.co/fiPXlb1y39
January 15th 2019, 7:01am
WeekHerald @WeekHerald
Cara Therapeutics $CARA Lowered to Sell at Zacks Investment Research https://t.co/BMnEImR4Ov
January 15th 2019, 7:01am
BioStocks @BioStocks
$CARA initiated at Neutral at BofA/Merrill. PT $19
January 15th 2019, 6:01am
AlexBo6 @AlexBo6
$CARA downhill ride home to 12-13 not J-hook up with that pot https://t.co/yrdvTwhFUK
January 14th 2019, 8:01pm
registrarjourn @registrarjourn
Cara Therapeutics $CARA Cut to “Sell” at Zacks Investment Research https://t.co/pnEzAIOD1x
January 14th 2019, 8:01pm
EnterpriseLeade @EnterpriseLeade
Cara Therapeutics $CARA Cut to “Sell” at Zacks Investment Research https://t.co/DSZWu7OK5n
January 14th 2019, 8:01pm
WatchlistN @WatchlistN
Cara Therapeutics $CARA Downgraded by Zacks Investment Research to “Sell” https://t.co/1L4ehEhWwd
January 12th 2019, 10:01am
TranscriptDaily @TranscriptDaily
Cara Therapeutics Inc $CARA Expected to Post Quarterly Sales of $3.35 Million https://t.co/ubJZk2HAlV
January 11th 2019, 9:01pm
ChartMill @ChartMill
$CARA has a poor technical rating and the quality of the setup is also only medium at the moment.… https://t.co/abcSUAFuBI
January 11th 2019, 9:01pm
dispatchtribune @dispatchtribune
Zacks Investment Research Downgrades Cara Therapeutics $CARA to Sell https://t.co/R4jsVe6G8o
January 11th 2019, 1:01pm
TranscriptDaily @TranscriptDaily
Cara Therapeutics $CARA Downgraded by Zacks Investment Research https://t.co/BZQBPrlCfW
January 11th 2019, 1:01pm
oldtrader60 @oldtrader60
$CARA I like the V bottom on this one. At the low it traded 2X normal daily volume. This is a Pot play as well https://t.co/9NEtuLQ0dE
January 11th 2019, 12:01pm
tradingmy2cents @tradingmy2cents
Bought back call options on $CGC and $CARA
January 11th 2019, 10:01am
StockNewsWires @StockNewsWires
$CARA $FMS: Here’s Why Cara Therapeutics Fell 28.5% in December: https://t.co/UmfSy0z5ln
January 10th 2019, 9:01pm
tradingmy2cents @tradingmy2cents
Closed $CGC and $CARA LEAP options to lock in gain (no position)
January 10th 2019, 1:01pm
OlympiaReport @OlympiaReport
Zacks Investment Research Downgrades Cara Therapeutics $CARA to Sell https://t.co/iDeufGndwN
January 10th 2019, 5:01am
WeekHerald @WeekHerald
Cara Therapeutics $CARA Downgraded to Sell at Zacks Investment Research https://t.co/CeMw5e0F86
January 10th 2019, 5:01am
dakotafinancial @dakotafinancial
Cara Therapeutics $CARA Lowered to “Sell” at Zacks Investment Research https://t.co/tZeOrCbJpu
January 9th 2019, 1:01pm
macondailynews @macondailynews
Cara Therapeutics $CARA Downgraded to Sell at Zacks Investment Research https://t.co/Q3fKJwaQni
January 9th 2019, 1:01pm
OlympiaReport @OlympiaReport
$3.35 Million in Sales Expected for Cara Therapeutics Inc $CARA This Quarter https://t.co/0pL8bJ7V7n
January 9th 2019, 12:01pm
WeekHerald @WeekHerald
$3.35 Million in Sales Expected for Cara Therapeutics Inc $CARA This Quarter https://t.co/TLWv87ZTFJ
January 9th 2019, 12:01pm
AlpacaAlerts @AlpacaAlerts
$CARA is in Dark Cloud Cover winning 80.00% in the past. https://t.co/NSH9e0NeMQ
January 9th 2019, 1:01am
ConsumerFeed @ConsumerFeed
Zacks Investment Research Lowers Cara Therapeutics $CARA to Sell https://t.co/TrL0YmsHvx
January 8th 2019, 7:01pm
DeepSouthDoctor @DeepSouthDoctor
Getting interested in $CARA after having quit following them past few years. Intrigued by their pipeline progress,… https://t.co/u2159f1f4G
January 8th 2019, 8:01am
MaisaCorp @MaisaCorp
$CARA Completes Enrollment of Phase 3 Trial of KORSUVA in Hemodialysis Patients With Pruritus
January 7th 2019, 3:01pm
SwingTradeBot @SwingTradeBot
Recent $CARA technical alerts: New Uptrend plus 7 more alerts... https://t.co/fyIsqa3hPp
January 7th 2019, 1:01pm
AlexBo6 @AlexBo6
$CARA #trade good news #korsuva
January 7th 2019, 12:01pm
bbnsnews @bbnsnews
Zacks: Analysts Anticipate Cara Therapeutics Inc $CARA Will Post Quarterly Sales of $3.35 Million https://t.co/TXr3MxwpiM
January 7th 2019, 10:01am
MarijuanaStocks @MarijuanaStocks
$CARA Completes Enrollment of KALM-1 Pivotal Phase 3 Trial Of KORSUVA™ https://t.co/VQ3PSgvLE2
January 7th 2019, 7:01am
BioStocks @BioStocks
$CARA Completes Enrollment of KALM-1 Pivotal Phase 3 Trial Of KORSUVA Injection in Hemodialysis Patients with Pruritus. Topline Data Q2
January 7th 2019, 7:01am
RyanSTTrader @RyanSTTrader
$CARA This company is pure dogsh*t - we don’t care for the theatrics anymore and management spin PR jobs are getting stale
January 7th 2019, 7:01am
odibro @odibro
$CARA Completes Enrollment of KALM-1 Pivotal Phase 3 Trial Of KORSUVA™ (CR845/ difelikefalin) Injection in Hemodial… https://t.co/63TiqYIn8a
January 7th 2019, 7:01am
ZolmaxNews @ZolmaxNews
Insider Selling: Cara Therapeutics Inc $CARA CEO Sells $272,200.00 in Stock https://t.co/JfMiRjWkLX
January 7th 2019, 5:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.